Can You Have ET With Negative JAK2, CALR, and MPL Tests?

Yes, you can absolutely still have essential thrombocythemia (ET) even if you test negative for the three most common genetic mutations: JAK2, CALR, and MPL ^[1].

Testing negative for these specific genetic markers does not invalidate your diagnosis. Instead, it means you fall into a subgroup known as triple-negative ET ^[1]. While it can be frustrating not to have a clear genetic marker to point to, you are not alone in this—research shows that approximately 8% to 15% of people diagnosed with ET are triple-negative ^[2][3].

What “Triple-Negative” Means

• It DOES mean: The standard laboratory assays did not detect the JAK2, CALR, or MPL driver mutations in your blood or bone marrow.
• It DOES NOT mean: Your condition is imaginary, your platelets are normal, or you are completely free of blood clot risks.

How Triple-Negative ET is Diagnosed

Because you lack the standard genetic markers, diagnosing triple-negative ET requires a rigorous, integrated approach ^[1]. Clinicians generally look for:

1. Sustained High Platelets: A platelet count of 450 $\times$ 10^9/L or higher that persists over time ^[4].
2. A Supportive Bone Marrow Biopsy: The biopsy is a central part of the diagnostic assessment ^[5]. A specialist called a hematopathologist (a doctor who studies blood and bone marrow diseases) looks directly at your marrow cells. They look specifically for megakaryocytes (the large cells that produce platelets) that are fully mature, larger than normal, and grouped in loose clusters ^[1][6].
3. Exclusion of Other Conditions: The biopsy and blood tests help distinguish ET from similar bone marrow disorders, such as chronic myeloid leukemia (CML), polycythemia vera (PV), and prefibrotic primary myelofibrosis (pre-PMF, a different bone marrow disorder that can closely resemble ET) ^[7][1].

Ruling Out “Reactive” Causes

Your care team must also verify that your high platelets are not a secondary response to another health issue. This is known as reactive thrombocytosis ^[8]. Common factors that can temporarily or chronically raise your platelet count include:

• Iron deficiency anemia
• Chronic inflammation or active infections
• Recent surgeries or the removal/dysfunction of your spleen (which raises counts because the spleen is no longer clearing old platelets from the blood, rather than the marrow overproducing them) ^[8]

Doctors evaluate this by checking iron studies, inflammatory markers, and blood count trends. It is important to note that reactive causes, such as iron deficiency, can sometimes coexist with true ET ^[8][9].

The Role of Broader Genetic Testing (NGS)

Your hematologist may recommend a broader genetic test called Next-Generation Sequencing (NGS) ^[9]. NGS can provide supporting context by finding:

• Non-canonical mutations: Rare, unusual variations of the JAK2 or MPL mutations that standard mutation panels are not designed to catch ^[10].
• Other markers of clonality: Mutations in genes like TET2 that suggest your cells are copying themselves from a single abnormal cell (clonality). However, TET2 mutations can naturally occur with aging (a state called clonal hematopoiesis) and are not specific proof of ET on their own ^[6].
• Inherited conditions: Rare genetic traits passed down in families (hereditary thrombocytosis). Routine NGS alone cannot always prove a mutation is inherited; this often requires looking closely at family history and performing specialized testing ^[11].

A negative NGS result does not rule out ET if your bone marrow and clinical signs strongly point to the disease ^[9].

How Does Triple-Negative Status Affect Risk and Treatment?

Patients often wonder if lacking these mutations changes their outlook. Observational studies suggest that triple-negative ET is generally associated with a lower risk of blood clots compared to JAK2-mutated ET ^[12][13].

However, your risk is not zero. Mutation status is only one piece of the puzzle. When planning care—such as deciding whether to use daily aspirin or platelet-lowering medications—doctors also evaluate your age, previous history of blood clots, cardiovascular risk factors (like blood pressure and cholesterol), and bleeding risks ^[14]. Do not start, stop, or change aspirin or other medications without consulting your doctor, as bleeding risks must be carefully weighed against clotting risks.

When to Seek Immediate Help: Regardless of your mutation status, always seek emergency medical care if you experience warning signs of a blood clot, such as sudden weakness or numbness, difficulty speaking, chest pain, shortness of breath, a painful swollen leg, or sudden severe vision changes.